Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

NCT00066677 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Stopped accordining to early stopping rule for futility

Conditions

Pancreatic Cancer

Interventions

DRUG: rhuMAB-VEGF
DRUG: docetaxel

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]